These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 32710249)
1. Prevalence of Acute Hypersensitivity Reactions in Pediatric Patients Receiving Crotalidae Polyvalent Immune Fab. Corbett B; Otter J; Masom CP; Clark RF J Med Toxicol; 2021 Jan; 17(1):48-50. PubMed ID: 32710249 [TBL] [Abstract][Full Text] [Related]
2. Incidence of allergic reactions to Crotalidae polyvalent immune Fab. Khobrani M; Huckleberry Y; Boesen KJ; Aljabri A; Alharthi M; Patanwala AE Clin Toxicol (Phila); 2019 Mar; 57(3):164-167. PubMed ID: 30260274 [TBL] [Abstract][Full Text] [Related]
3. Acute hypersensitivity reaction to Crotalidae polyvalent immune Fab (CroFab) as initial presentation of galactose-α-1,3-galactose (α-gal) allergy. Rizer J; Brill K; Charlton N; King J Clin Toxicol (Phila); 2017 Aug; 55(7):668-669. PubMed ID: 28443380 [TBL] [Abstract][Full Text] [Related]
4. Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune Fab antivenom. Cannon R; Ruha AM; Kashani J Ann Emerg Med; 2008 Apr; 51(4):407-11. PubMed ID: 18191286 [TBL] [Abstract][Full Text] [Related]
5. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation. Offerman SR; Bush SP; Moynihan JA; Clark RF Pediatrics; 2002 Nov; 110(5):968-71. PubMed ID: 12415038 [TBL] [Abstract][Full Text] [Related]
6. Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation. Keating GM BioDrugs; 2011 Apr; 25(2):69-76. PubMed ID: 21443271 [TBL] [Abstract][Full Text] [Related]
8. Adverse Events in the Efficacy of Crotalidae Polyvalent Immune Fab Antivenom vs Placebo in Recovery from Copperhead Snakebite Trial. Mullins ME; Gerardo CJ; Bush SP; Rose SR; Greene S; Quackenbush EB; Lewis B; Anderson VE; Kleinschmidt KC; Schwarz RB; Charlton NP; Toschlog EA; Sharma K; Denning DA; Lavonas EJ South Med J; 2018 Dec; 111(12):716-720. PubMed ID: 30512122 [TBL] [Abstract][Full Text] [Related]
9. Severe adverse drug reaction following Crotalidae Polyvalent Immune Fab (Ovine) administration for copperhead snakebite. Lepak MR; Bochenek SH; Bush SP Ann Pharmacother; 2015 Jan; 49(1):145-9. PubMed ID: 25341425 [TBL] [Abstract][Full Text] [Related]
10. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Dart RC; Seifert SA; Boyer LV; Clark RF; Hall E; McKinney P; McNally J; Kitchens CS; Curry SC; Bogdan GM; Ward SB; Porter RS Arch Intern Med; 2001 Sep; 161(16):2030-6. PubMed ID: 11525706 [TBL] [Abstract][Full Text] [Related]
11. Recovery from Copperhead Snake Envenomation: Role of Age, Sex, Bite Location, Severity, and Treatment. Lavonas EJ; Burnham RI; Schwarz J; Quackenbush E; Lewis B; Rose SR; Greene S; Toschlog EA; Charlton NP; Mullins ME; Schwartz R; Denning D; Sharma K; Kleinschmidt K; Bush SP; Anderson VE; Ginde AA; Gerardo CJ J Med Toxicol; 2020 Jan; 16(1):17-23. PubMed ID: 31482319 [TBL] [Abstract][Full Text] [Related]
12. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial. Bush SP; Ruha AM; Seifert SA; Morgan DL; Lewis BJ; Arnold TC; Clark RF; Meggs WJ; Toschlog EA; Borron SW; Figge GR; Sollee DR; Shirazi FM; Wolk R; de Chazal I; Quan D; García-Ubbelohde W; Alagón A; Gerkin RD; Boyer LV Clin Toxicol (Phila); 2015 Jan; 53(1):37-45. PubMed ID: 25361165 [TBL] [Abstract][Full Text] [Related]
13. Rational use of crotalidae polyvalent immune Fab (ovine) in the management of crotaline bite. Yip L Ann Emerg Med; 2002 Jun; 39(6):648-50. PubMed ID: 12023708 [No Abstract] [Full Text] [Related]
14. Acute adverse events associated with the administration of Crotalidae polyvalent immune Fab antivenom within the North American Snakebite Registry. Kleinschmidt K; Ruha AM; Campleman S; Brent J; Wax P; Clin Toxicol (Phila); 2018 Nov; 56(11):1115-1120. PubMed ID: 29688079 [No Abstract] [Full Text] [Related]
15. The use and tolerability of Crotalidae Polyvalent Immune FAB (Ovine) in pediatric envenomations. Farrar HC; Grayham T; Bolden B; Vyas D; Graham J; James LP Clin Pediatr (Phila); 2012 Oct; 51(10):945-9. PubMed ID: 22511193 [TBL] [Abstract][Full Text] [Related]
16. Use of both Fab and F(ab') Martin AM; Wang GS; Poel K Am J Emerg Med; 2021 Jul; 45():677.e1-677.e3. PubMed ID: 33293188 [TBL] [Abstract][Full Text] [Related]
17. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite. Lavonas EJ; Kokko J; Schaeffer TH; Mlynarchek SL; Bogdan GM; Dart RC Ann Emerg Med; 2011 Feb; 57(2):128-137.e3. PubMed ID: 20952098 [TBL] [Abstract][Full Text] [Related]
18. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ruha AM; Curry SC; Beuhler M; Katz K; Brooks DE; Graeme KA; Wallace K; Gerkin R; Lovecchio F; Wax P; Selden B Ann Emerg Med; 2002 Jun; 39(6):609-15. PubMed ID: 12023703 [TBL] [Abstract][Full Text] [Related]
19. Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom. Clark RF; McKinney PE; Chase PB; Walter FG Ann Emerg Med; 2002 Jun; 39(6):671-6. PubMed ID: 12023714 [TBL] [Abstract][Full Text] [Related]
20. Copperhead snakebite treated with crotalidae polyvalent immune fab (ovine) antivenom in third trimester pregnancy. Kravitz J; Gerardo CJ Clin Toxicol (Phila); 2006; 44(3):353-4. PubMed ID: 16749561 [No Abstract] [Full Text] [Related] [Next] [New Search]